Thesis (PhD (Biomedical Sciences. Medical Physiology))--University of Stellenbosch, 2006. / Early life trauma leads to behavioural abnormalities later in life. These include mood and anxiety disorders such as depression and posttraumatic stress disorder (PTSD). This association may be due in part to the effects of trauma on brain development. Data from basic and clinical experiments suggest that alterations in the hippocampus may be fundamental to the development of these disorders. Here we used an animal model of early life trauma to investigate its effects on the behaviour and neurochemistry of the adult rat. Adolescent rats were subjected to time-dependent sensitization stress consisting of a triple stressor (2 hours restraint, 20 min swim stress and exposure to ether vapour) on post-natal day (PND) 28, a single re-stress on PND 35 (20 min swim stress), and a second re-stress in adulthood (PND 60, 20 min swim stress). The rationale was that the frequency of exposure to situational reminders contributes to the maintenance over time of fear-related behavioural disturbances. The effects of trauma on the hypothalamus-pituitary-adrenal-axis, hippocampal and plasma neurotrophin levels, behaviour and phosphoinositide-3 kinase (PI-3 kinase) signaling proteins were initially investigated. In addition, proteomic technologies such as protein arrays and 2D-SDS PAGE combined with liquid chromatography tandem mass spectrometry (LC-MS/MS) were employed to study trauma-induced effects on the hippocampus. Traumatized animals showed a decrease in glucocorticoid receptors in the dentate gyrus of the hippocampus and an increase in basal corticosterone levels 24 hours after adulthood re-stress. These effects were reversed by pretreatment with the serotonin selective reuptake inhibitor, escitalopram. A decrease in the neurotrophins, BDNF and NT-3 were evident 8 days, but not 24 hours after adulthood re-stress. This decrease was not accompanied by decreases in plasma neurotrophin or PI-3 kinase, protein kinase B (PKB), phosphatase and tensin homologue (PTEN), phospho-forkhead and phospho-AFX protein levels. In addition, traumatized animals showed increased rearing in both the elevated plus maze and open field. Proteomic analysis of trauma-induced changes in the hippocampus show increases in Ca2+ homeostasis / signaling proteins such as S-100B, phospho-JNK and calcineurin. Apoptotic initiator proteins, including caspase 9, -10 and -12 were increased and there was evidence of cytoskeletal protein dysregulation. Furthermore, cell cycle regulators and energy metabolism proteins were decreased. These effects indicate to a cellular state of cell cycle arrest after increased calcium influx to avoid apoptosis. Our data suggest that adolescent trauma with adulthood re-stress may affect numerous systems at different levels. These include neuroendocrine-, protein systems and behaviour, and confirmed that a systems biology approach is needed for a better understanding of the neurobiology of mental disorders.

Quinolinate phosphoribosyltransferase (QPRTase, EC 2.4.2.19) is an intriguing enzyme which appears to catalyse two distinct chemical reactions; transfer of a phosphoribosyl moiety from 5-phosphoribosyl-1-pyrophosphate to the nitrogen of quinolinic acid and decarboxylation at the 2-position to give nicotinic acid mononucleotide. The chemical mechanism of QPRTase is not fully understood. In particular, enzymatic involvement in the decarboxylation step is yet to be conclusively proven. QPRTase is neurologically important as it degrades the potent neurotoxin, quinolinic acid, implicated in diseases such as Huntington’s disease and AIDS related dementia. Due to its neurological importance and unusual chemistry the mechanism of QPRTase is important. Described here is a mechanistic study on human brain QPRTase. Human brain QPRTase was successfully expressed in E. coli BL21 (DE3) from the pEHISTEV-QPRTase construct and the protein was efficiently purified by nickel affinity chromatography. The crystal structure was solved using multiwavelength methods to a resolution of 1.9 Å. Human brain QPRTase was found to adopt an energetically stable hexameric arrangement. The enzyme was also found to exist as a hexamer during gel filtration under physiological conditions. Kinetic studies allowed the measurement of the kinetic parameters for quinolinic acid. The data gave a Km of 13.4 ± 1.0 μM and a Vmax of 0.92 ± 0.01 μM min-1. There was no evidence for cooperative binding of quinolinic acid to the six subunits of the QPRTase hexamer. The enzyme showed maximum activity at approximately pH 6. The active site of human brain QPRTase is a deep pocket with a highly positive electrostatic surface composed of three arginine residues, two lysine residues and one histidine residue. Mutation of these residues resulted in either complete loss or significant reduction in enzymatic activity showing they are important for binding and/or catalysis. A possible mechanism involving QPRTase in the decarboxylation of quinolinic acid mononucleotide was proposed. A series of quinolinic acid analogues were synthesised and tested as inhibitors of QPRTase. The inhibition studies highlighted some key interactions in the active site.

La documentation scientifique fait état de la présence, chez l’adulte, de cellules souches et progénitrices neurales (CSPN) endogènes dans les zones sous-ventriculaire et sous-granulaire du cerveau ainsi que dans le gyrus denté de l’hippocampe. De plus, un postulat selon lequel il serait également possible de retrouver ce type de cellules dans la moelle épinière et le néocortex des mammifères adultes a été énoncé. L’encéphalopathie de Wernicke, un trouble neurologique grave toutefois réversible qui entraîne un dysfonctionnement, voire une défaillance du cerveau, est causée principalement par une carence importante en thiamine (CT). Des observations récentes laissent envisager que les facteurs en cause dans la prolifération et la différenciation des CSPN pourraient également jouer un rôle important lors d’un épisode de CT. L’hypothèse, selon laquelle l’identification de nouveaux métabolites entrant dans le mécanisme ou la séquence de réactions se soldant en une CT pourraient en faciliter la compréhension, a été émise au moyen d'une démarche en cours permettant d’établir le profil des modifications métaboliques qui surviennent en de telles situations. Cette approche a été utilisée pour constater les changements métaboliques survenus au niveau du foyer cérébral dans un modèle de rats déficients en thiamine (rats DT), particulièrement au niveau du thalamus et du colliculus inférieur (CI). La greffe de CSPN a quant à elle été envisagée afin d’apporter de nouvelles informations sur la participation des CSPN lors d’un épisode de CT et de déterminer les bénéfices thérapeutiques potentiels offerts par cette intervention. Les sujets de l’étude étaient répartis en quatre groupes expérimentaux : un premier groupe constitué de rats dont la CT était induite par la pyrithiamine (rats DTiP), un deuxième groupe constitué de rats-contrôles nourris ensemble (« pair-fed control rats » ou rats PFC) ainsi que deux groupes de rats ayant subi une greffe de CSPN, soit un groupe de rats DTiP greffés et un dernier groupe constitué de rats-contrôles (rats PFC) greffés. Les échantillons de foyers cérébraux (thalamus et CI) des quatre groupes de rats ont été prélevés et soumis à des analyses métabolomiques non ciblées ainsi qu’à une analyse visuelle par microscopie à balayage électronique (SEM). Une variété de métabolites-clés a été observée chez les groupes de rats déficients en thiamine (rats DTiP) en plus de plusieurs métabolites dont la documentation ne faisait pas mention. On a notamment constaté la présence d’acides biliaires, d’acide cynurénique et d’acide 1,9— diméthylurique dans le thalamus, alors que la présence de taurine et de carnosine a été observée dans le colliculus inférieur. L’étude a de plus démontré une possible implication des CSPN endogènes dans les foyers cérébraux du thalamus et du colliculus inférieur en identifiant les métabolites-clés ciblant les CSPN. Enfin, les analyses par SEM ont montré une amélioration notable des tissus à la suite de la greffe de CSPN. Ces constatations suggèrent que l’utilisation de CSPN pourrait s’avérer une avenue thérapeutique intéressante pour soulager la dégénérescence symptomatique liée à une grave carence en thiamine chez l’humain. / Endogenous neural-stem progenitor cells (NSPC) have been documented to be found in the subventricular and subgranular zones, the dentate gyrus, and suggestions of the possibility of these cells being found in the spinal cord and neocortex in adult mammalian brain have been postulated. Thiamine deficiency (TD) is the major cause of Wernicke's Encephalopathy, a reversible neurological disorder that results in cerebral dysfunction and impairment. Recent evidence suggests factors involved in neural NSPC proliferation and differentiation are involved during TD. By means of a current approach for profiling metabolic changes occurring in focal areas of the TD rat brain, specifically the thalamus and the inferior colliculus (IC), it was hypothesized that new metabolites that might offer a better understanding into the sequel and/or mechanism of TD could be identified. It was also considered that the use of NSPC transplantation could offer new information into the involvement of NSPC and potential therapeutic benefit in TD. Non-targeted metabolomics analysis, fluorescences microscopy, and scanning election microscopy (SEM) analysis visualization was performed on samples of the focal areas (thalamus and IC) of pyrithiamine induced TD rats (PTD), pair-fed controls (PFC) rats, and NSPC transplanted TD and PFC rats. Various key metabolites were identified in rats with TD, including previous undocumented metabolites such as bile acids, kynurenic acid, and 1,9-dimethyluric acid in the thalamus and taurine and carnosine in the IC. The study also demonstrated a possible involvement of endogenous NSPC in focal areas of the thalamus and IC identifying key metabolites targeting NSPC and showed tissue amelioration (observed through SEM) following NSPC transplantation. The findings suggested that NSPC could offer a therapeutic alternative to alleviate some of symptomatic degeneration of TD.

Um aumento da atividade da PLA2 e alterações do sistema dopaminérgico tem sido descrito em esquizofrenia. No presente estudo, foram investigados os efeitos da atividade da PLA2 sobre os receptores D1 e D2 em cérebro post mortem de 10 sujeitos. Foi encontrado que a PLA2GVI é responsável por 85% do total de atividade da PLA2 no cérebro. A estimulação da PLA2GVI (por EDTA) aumentou a afinidade de D1 em estriado e em CPF e diminuiu a afinidade de D2 em estriado. A inibição da PLA2GVI (por BEL) diminuiu a afinidade de D1 em estriado, e em CPF e CT. A estimulação da PLA2GVI resultou em aumento na densidade de D1 em CPF e CT, e de D2 em estriado. Uma elevação da PLA2 em esquizofrenia poderia contribuir para a biologia da doença através de alterações na neurotransmissão dopaminérgica / Increased PLA2 activity and dopaminergic alterations have been described in schizophrenia. In the present study it was investigated the effects of PLA2 activity on D1 and D2 receptors in post mortem brain of 10 subjects. It was found that PLA2GVI corresponds to 85% of all PLA2 activity in the brain. The stimulation of PLA2GVI (by EDTA) increased D1 affinity in striatum and in PFC, and decreased D2 affinity in striatum. Conversely, the inhibition of PLA2GVI (using BEL) decreased D1 affinity in striatum, PFC and TC. The stimulation of PLA2GVI increased D1 density in PFC and TC, as well as the D2 density in striatum. The increased PLA2 activity in schizophrenia may contribute to the biology of the disease through alterations in dopaminergic neurotransmission

Injeções repetidas de psicoestimulantes e/ou compostos opióides desencadeiam respostas comportamentais, bioquímicas, endócrinas e celulares diferentes daquelas induzidas pela exposição aguda. Em particular, a morfina, considerada como o protótipo do estimulante opioidérgico, tem despertado grande interesse devido a seus efeitos múltiplos. Assim, no presente estudo avaliaram-se as consequências dos tratamentos agudo e repetido com morfina (20mg/kg) em camundongos sobre os seguintes aspectos: atividade geral; níveis séricos de corticosterona; concentrações corticais, estriatais e hipotalâmicas de noradrenalina, dopamina e serotonina, de seus metabólitos e as taxas de renovação destes neurotransmissores; atividade funcional ex vivo de neutrófilos sanguíneos e de macrófagos peritoneais, sendo estes desafios realizados in vivo com diferentes estímulos imunológicos, infecciosos ou não; crescimento tumoral e a sobrevida de camundongos portadores de um tumor ascítico de Ehrlich. Os resultados obtidos mostraram que os tratamentos agudo e repetido com morfina modulam diferentemente as repostas comportamental e neuroendócrina, dependendo do tempo de observação pós-desafio. Portanto, conclui-se que camundongos tratados repetidamente com morfina (20mg/kg) apresentam alterações comportamentais e neuroendócrinas que, no entanto, não foram acompanhadas por diferenças nas avaliações de atividade imune inata. / Repeated administrations of psychostimulant and/or opioid compounds trigger different behavioral, biochemical, endocrine and cellular responses as compared with those induced by acute exposure. Morphine, has attracted great interest due to its multiple effects. Thus, this study evaluated the effects of acute and repeated treatment with morphine (20mg/kg) in mice on the following: locomotor activity; serum levels of corticosterone; cortical, striatal and hypothalamic concentration of dopamine, noradrenaline and serotonin, as well as their metabolites and turnover; blood neutrophils and peritoneal macrophage activity ex vivo, which were challenged with different immunological stimulants; tumor growth and survival of mice with Erlich ascitic tumor. The results showed that acute and repeated morphine treatment differently modulated behavioral and neuroendocrine responses, depending on the these period after the injection challenge. Thus, it is concluded that mice repeatedly treated with morphine (20mg/kg) present behavioral and neuroendocrine changes; however, this changes were not accompanied by variation in innate immune activity.

http://www.pharmacol.usyd.edu.au/thesis This thesis is primarily concerned with a class of chemical compounds known as pyridazinediones, being 6-membered aromatic rings containing two adjacent nitrogen atoms (pyridazine), doubly substituted with oxygen. In particular, the work focuses on pyridazine-3,6-diones, derivatives of maleic hydrazide (1). Understanding of the chemistry of these compounds is extended, using theoretical and synthetic techniques. This thesis is also concerned with two very important classes of receptors which bind amino acids in the brain: firstly, the inhibitory GABA receptor, which binds g-aminobutyric acid (GABA) (2) in vivo, and for which muscimol (3) is an agonist of the GABAA subclass; secondly, Excitatory Amino Acid (EAA) receptors, which bind glutamate (4) in vivo, and in particular the AMPA subclass, for which (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) (5) is an agonist. The connection between pyridazinediones and amino acid receptors is the design, synthesis, and evaluation of structures based on pyridazinediones as potential GABA and EAA receptor ligands. Techniques of theoretical chemistry, molecular modelling, synthetic chemistry, and in vitro pharmacology are used to explore pyridazine-3,6-dione derivatives as ligands.

http://www.pharmacol.usyd.edu.au/thesis This thesis is primarily concerned with a class of chemical compounds known as pyridazinediones, being 6-membered aromatic rings containing two adjacent nitrogen atoms (pyridazine), doubly substituted with oxygen. In particular, the work focuses on pyridazine-3,6-diones, derivatives of maleic hydrazide (1). Understanding of the chemistry of these compounds is extended, using theoretical and synthetic techniques. This thesis is also concerned with two very important classes of receptors which bind amino acids in the brain: firstly, the inhibitory GABA receptor, which binds g-aminobutyric acid (GABA) (2) in vivo, and for which muscimol (3) is an agonist of the GABAA subclass; secondly, Excitatory Amino Acid (EAA) receptors, which bind glutamate (4) in vivo, and in particular the AMPA subclass, for which (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) (5) is an agonist. The connection between pyridazinediones and amino acid receptors is the design, synthesis, and evaluation of structures based on pyridazinediones as potential GABA and EAA receptor ligands. Techniques of theoretical chemistry, molecular modelling, synthetic chemistry, and in vitro pharmacology are used to explore pyridazine-3,6-dione derivatives as ligands.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / In recent years have been identifical numerous pharmacological properties of a selenium compound, diphenyl diselenide [(PhSe)2]. Consequently, it is important the investigation of its toxic effect for a safe application in pharmacological studies. It is known that babies, in particular, have many physiological and biochemical changes related to development, which increase the susceptibility to toxic effects of drugs. Thus, the article 1 investigated the appearance of seizure episodes induced by (PhSe)2 when administered orally at doses of 5 to 500 mg/kg in rat pups (pos natal day 12-14) and the possible glutamatergic (article 2) and GABAergic (article 3) mechanisms involved in this process. Some studies using different experimental models have demonstrated the most different pharmacological and toxicodynamics properties of (PhSe)2. However, little is known about the toxicokinetic disposition of this compound. Therefore, the aim of article 4 was to determine and quantify the plasma levels of (PhSe)2 in adult mice and rats after oral (p.o.) administration of 500 mg/kg (PhSe)2; to verify the involvement of different routes of administration, vehicle and animal species in plasma levels of (PhSe)2 and in the onset of the first seizure episode induced by it. In article 5, it was determined and quantified the levels of (PhSe)2 in plasma, liver and brain of rat pups and these levels were correlated to the latency for the onset of the first seizure episode. To obtain more information about the compound, which were to supplement the data obtained, we carried out in vitro kinetic models. The manuscript 1 investigated the drug-like properties of (PhSe)2 in regards to stability, solubility, absorption and plasma protein binding (PPB) in vitro. In manuscript 2, it was conducted an in vitro study in order to identify possible metabolic pathways responsible for the biotransformation of (PhSe)2 in the body. Results of article 1 showed that administration of (PhSe)2 caused toxicity in rat pups, evidenced by the appearance of seizures. These were dose dependent and were, at least in part, related to oxidative stress. Among the mechanisms involved in the convulsive effect of (PhSe)2 were the interaction with: glutamatergic system by stimulating the inotropic glutamatergic receptors NMDA and by inhibiting the uptake of glutamate (Article 2); GABAergic system by antagonize the GABAA receptor, stimulating GABA transaminase enzyme and increasing GABA uptake (Article 3). The article 4 revealed that the maximum concentration of (PhSe)2 in the plasma of adult rats and mice occurred 30 minutes after p.o administration of the compound and remained detectable up to 8 hours after administration. The use of different routes of administration (intraperitoneal (i.p.), p.o., subcutaneous (s.c.)) or vehicle (canola oil or dimethyl sulfoxide (DMSO)) in rats and mice indicated that the onset of the first seizure episode and plasma levels are dependent on the route of administration (i.p. > p.o. > s.c.), vehicle (DMSO > canola oil) and animal species (mouse > rat). In article 5, it was observed that rat pups showed seizures even presenting lower plasma values of (PhSe)2 as compared to adults. This result demonstrated that rat pups are more sensitive to the toxic effects of (PhSe)2 than adult rats. Levels of (PhSe)2 in the liver and brain of rat pups showed a negative correlation with the latency to the first seizure episode. The manuscript 1 showed that (PhSe)2 has chemical and biological stability. However, the compound has a low solubility in water, a high partition coefficient octanol-water and an extensive plasma protein binding. Manuscript 2 indicated that (PhSe)2 is not biotranformed by Phase I reactions, catalyzed by cytochrome P450. It reacted chemically with reduced glutathione (GSH) and N-acetylcysteine (NAC) to form adducts or reacts with protein SH groups. The presence of GSH or NAC in the incubation medium decreased the binding of (PhSe)2 protein. Finally, it was observed that (PhSe)2 reduced the activity of cytochrome P450. Together, the data presented showed that the intensity of toxic effects caused by (PhSe)2 are directly related to its toxicokinetic. / Nos últimos anos, têm sido identificadas inúmeras propriedades farmacológicas do composto de selênio disseleneto de difenila [(PhSe)2]. Assim, a pesquisa dos efeitos tóxicos deste composto torna-se importante para a segurança na aplicação farmacológica. Sabe-se que os bebês, em particular, apresentam muitas mudanças fisiológicas e bioquímicas relacionadas ao desenvolvimento, que aumentam a suscetibilidade aos efeitos tóxicos de drogas. Desta forma, no artigo 1 investigou-se o aparecimento de convulsões induzida pelo (PhSe)2, quando administrado pela via oral (p.o), nas doses de 5 à 500 mg/kg em ratos bebês (12-14 dias de vida) bem como os possíveis mecanismos glutamatérgicos (Artigo 2) e GABAérgicos (Artigo 3) envolvidos em tal processo. Vários estudos, utilizando diferentes modelos experimentais demonstraram as mais diferentes propriedades farmacológicas e toxicodinâmicas do (PhSe)2 no entanto, pouco se conhece sobre a toxicodinâmica deste composto. Por isso, o objetivo do artigo 4 foi determinar e quantificar os níveis plasmáticos de (PhSe)2 em ratos e camundongos adultos após a administração p.o. de (PhSe)2 na dose de 500 mg/kg; bem como verificar o envolvimento de diferentes vias de administração, veículos e espécie animal nos níveis plasmáticos do composto e no aparecimento de convulsões induzidas pelo mesmo. No artigo 5, determinou-se e quantificou-se os níveis de (PhSe)2 no plasma, fígado e cérebro de ratos bebês e correlacionou-se estes níveis à latência para o aparecimento de convulsões. Devido a necessidade de obter mais informações sobre o composto, que viessem a complementar os dados obtidos, realizou-se modelos cinéticos in vitro. O manuscrito 1 investigou parâmetros relacionados a estabilidade, solubilidade, absorção e ligação às proteínas plasmáticas do (PhSe)2 in vitro. No manuscrito 2 realizou-se um estudo in vitro para identificar as vias metabólicas responsáveis pela biotransformação do (PhSe)2 no organismo. Os resultados do artigo 1 demonstraram que a administração de (PhSe)2 causou toxicidade em ratos bebês, evidenciada pelo aparecimento de convulsões. Estas são dependentes da dose utilizada e estão, pelo menos em parte, relacionadas ao estresse oxidativo. Dentre os mecanismos neuroquímicos envolvidos no efeito convulsivante do (PhSe)2 estão a interação com o sistema glutamatérgico, por estimular os receptores glutamatérgicos ionotrópicos do tipo NMDA e por inibir a captação de glutamato (Artigo 2); e com o sistema GABAérgico, por antagonizar os receptores GABAégicos do tipo GABAA, estimulando a enzima GABA transaminase e estimulando a captação de GABA (Artigo 3). O artigo 4 demonstrou que concentração máxima de (PhSe)2 no plasma de ratos e camundongos adultos ocorreu 30 minutos após a administração pela via oral do composto e permaneceu detectável até 8 horas após sua administração. O uso de diferentes vias de administração (intraperitonial (i.p); p.o; subcutânea (s.c)) e veículo (óleo de canola ou dimetil sulfóxido (DMSO)) em ratos e camundongos indicou que o aparecimento de convulsões e os níveis plasmáticos de (PhSe)2 são dependentes da via de administração (i.p > p.o > s.c), do veículo (DMSO > óleo de canola) e da espécie animal (camundongo > rato). No artigo 5 observou-se ainda que os ratos bebês convulsionaram mesmo apresentando níveis plasmáticos menores de composto que os adultos, o que nos leva a crer que estes são mais sensíveis aos feitos tóxicos do (PhSe)2. Os níveis de (PhSe)2 no fígado e no cérebro de ratos bebês no momento do episódio convulsivo apresentaram uma correlação negativa com a latência para o primeiro episódio convulsivo. O manuscrito 1 revelou que o (PhSe)2 apresenta estabilidade química e biológica. No entanto, o composto apresenta uma baixa solubilidade em água, um alto coeficiente de partição octanol-água e uma extensa ligação às proteínas plasmáticas. O manuscrito 2 indicou que o (PhSe)2 não é biotransformado por reações de fase I catalizadas pelo citocromo P450. O composto reage quimicamente com a glutationa reduzida (GSH) e a N-acetilciateína (NAC), formando adutos ou ainda reage com grupos SH de proteínas. A presença de GSH ou NAC no meio de incubação diminuiu a ligação do (PhSe)2 às proteínas. Por fim, foi observado que o (PhSe)2 reduziu a atividade das enzimas do citocromo P450. Em conjunto, os resultados desta tese demonstraram que a intensidade dos efeitos tóxicos causados pelo (PhSe)2 estão diretamente relacionados a sua toxicocinética.

Made available in DSpace on 2014-12-17T15:36:53Z (GMT). No. of bitstreams: 1 RaissaRL.pdf: 2340483 bytes, checksum: 4de24714e54fd592ed6bcfc320e45daf (MD5) Previous issue date: 2008-10-30 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior / The retinal projections in mammals usually reach, classically, three major functional systems: the primary visual system, the accessory optic system, and the circadian timing system. But the retinal projections also reach areas classically considered non-visual, one of which groups the neurons of the zona incerta (ZI), target this study. The primary visual system includes thalamic lateral geniculate complex is formed by the dorsal lateral geniculate nucleus, intergeniculate leaflet and the ventral lateral geniculate nucleus and other Components. The accessory optic system is composed of the small nuclei: nuclei terminal dorsal, lateral, medial and the interstitial nucleus of the superior posterior fasciculus. These nuclei are involved in visuo-motor activities. The circadian timing system is comprised of the suprachiasmatic nucleus of the hypothalamus, that act as master circadian pacemaker, entraining pathways and efferents pathways to the efectors, and the intergeniculate leaflet, that seems to act as a modulator of the pacemaker. The retinal projections too reach classically considered non-visual areas, including the zona incerta. This region is localized in the ventral thalamus and has been implicated in various functional properties including nociceptive and somatosensory processing, motor response, sociosexual behaviour, feeding and drinking, in symptoms of neurodegenerative diseases, arousal and attention. It also displays connection with several areas of central nervous system. The aim of this study was characterize the retinal projection in the zona incerta of Callithrix jacchus (sag?i), a primate of the New World through the anterograde axonal transport of the cholera toxin subunit b and analyze the citoarchicteture using Nissl and NeuN, and neurochemical substances such as serotonin, GABA, VIP, VP, GFAP and binding-calcium proteins. The zona incerta showed a different division of the literature in citoarquitetura, both by means of Nissl as neurochemical by NeuN, with a subdivision ventrolateral and dorsomedial. The neurochemical to the other substances corroborate with this subdivision. The GFAP was almost completely negative for the zona incerta, result non evidenced in previous studies yet. The 16 retinal projection in sag?i, unlike other primates and rodents, reached the caudal portion only. This work helps to make further studies are conducted based on this subdivision and the localization of the neurochemical substances associated with possible behaviors that the zona incerta is involved / As proje??es retinianas em mam?feros costumam ser agrupadas, classicamente, em tr?s grandes sistemas funcionais: O sistema visual prim?rio, o sistema ?ptico acess?rio e o sistema de temporiza??o circadiana. Por?m as proje??es retinianas tamb?m alcan?am locais considerados como classicamente n?o-visuais, um dos quais agrupa os neur?nios da zona incerta (ZI), alvo deste estudo. O sistema visual prim?rio inclui o complexo geniculado lateral tal?mico formado pelo n?cleo geniculado lateral dorsal, o folheto intergeniculado e o n?cleo geniculado lateral ventral, al?m de outros componentes. O sistema ?ptico acess?rio ? formado por pequenos n?cleos: n?cleos terminais dorsal, lateral, medial e o n?cleo intersticial do fasc?culo posterior superior. Estes n?cleos participam da atividade v?suo-motora. O sistema de temporiza??o circadiana ? composto pelo n?cleo supraquiasm?tico do hipot?lamo, tido como principal marcapasso circadiano, vias sincronizadoras e vias de sa?da aos efetores, e o folheto intergeniculado, que parece agir como modulador do marcapasso. As proje??es retinianas tamb?m alcan?am ?reas classicamente n?o-visuais, entre elas, a zona incerta. Esta regi?o est? localizada no t?lamo ventral e tem sido implicada em v?rias propriedades funcionais incluindo processamento somatosens?rio e nociceptivo, resposta motora, comportamento s?cio-sexual, de comer e beber, em sintomas de doen?as neurodegenerativas, despertar e aten??o. Apresenta tamb?m conex?o com diversas ?reas do sistema nervoso central proporcionando a esta regi?o a associa??o com diversas fun??es. O objetivo neste trabalho foi caracterizar a proje??o retiniana no Callithrix jacchus (sag?i), um primata do Novo Mundo, atrav?s do tra?ador anter?grado a unidade B da toxina col?rica, bem como analisar a citoarquitetura, utilizando o Nissl e NeuN, e a neuroqu?mica com subst?ncias neuroativas como a serotonina, o GABA, o VIP, VP, al?m de GFAP e prote?nas ligantes de c?lcio. A zona incerta apresentou uma divis?o diferenciada da presente na literatura na citoarquitetura, tanto pelo m?todo de Nissl como neuroqu?mico por NeuN, com uma subdivis?o ventrolateral e dorsomedial. A neuroqu?mica para as outras 14 subst?ncias corrobora com essa divis?o. O GFAP foi quase em completo negativo para a ZI, resultado este ainda n?o evidenciado em trabalhos anteriores. A proje??o retiniana no sag?i, diferentemente de outros primatas, e roedores, alcan?ou a por??o caudal somente. Este trabalho contribui para que novos estudos sejam realizados tomando por base essa subdivis?o bem como a localiza??o das subst?ncias neuroativas associadas a poss?veis comportamentos em que a zona incerta esteja envolvida

Made available in DSpace on 2014-12-17T15:37:21Z (GMT). No. of bitstreams: 1 PauloLAGM_DISSERT.pdf: 1515778 bytes, checksum: c044dde7997a56896121bcf83cf26e6b (MD5) Previous issue date: 2014-03-27 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior / The Zona Incerta (ZI) is embryologically derived from the ventral thalamus, in continuity with the reticular nucleus of the thalamus. Studies usingneural tracers technics have allowed identify a complex connectional map including the ZI. Futhermore, cytochemical, molecular and functional data have shown abundant variability in the neurochemical contend in the ZI, as well as,the involvement of the ZI in the modulation of nociception, attention, alertness, control and maintenance of posture and control of visceral activity. This work aims to characterize the cytoarchitecture, neurochemical content of the ZI in the rock cavy (Kerodon rupestris), and a direct retinal-ZI pathway present in this species. The Nissl staining is effective for the delineation and characterization of ZI citoarchitecture. ZIc receives a contralateral retinal projection showing varicosities, suggesting a modulatory character of photic information. The ZI in the rock cavy, as in others rodents and primates, is characterized by a complex neurochemical signature. The ZI neurochemistry presents great diversity, especially in the medial portion of ZIr, where we have found immunoreactivity of all neuroactive substances investigated, and that NOS-IR, GFAP and CR helped the delimitation of middle ZI in ZId and ZIv. Nevertheless, just 5-HT-IR fibers are present in all subdivisions of the ZI. These data demonstrate the great wealth of the neurochemistry of rock cavy s ZI and a direct retinal modulation in the ZI, helping to explain it s broad functional repertory / A Zona Incerta (ZI) ? um grupamento neuronal embriologicamente derivado do t?lamo ventral, em continuidade com o n?cleo reticular do t?lamo. Diversos estudos com tra?adores retr?grados e anter?grados revelaram a conex?o da ZI com diversas estruturas do sistema nervoso central. Dados moleculares e citoqu?micos revelaram que a ZI ? um dos grupamentos neuronais com maior diversidade neuroqu?mica e citoarquitet?nica do dienc?falo, e estudos hodol?gicos e neuroqu?micos permitiram considerar o envolvimento da ZI em diversas fun??es, as quais se destacam a nocicep??o, aten??o, estado de alerta, controle e manuten??o da postura e controle da atividade visceral. Este trabalho tem por objetivo caracterizar a citoarquitetura e o conte?do neuroqu?mico da ZI do moc? (Kerodon rupestris), bem como a afer?ncia ?ptica presente neste n?cleo nesta esp?cie. A t?cnica de Nissl ? eficiente para a delimita??o e caracteriza??o citoarquitet?nica da ZI do moc?; A ZIc recebe proje??o da retina contralateral, apresentando fibras Classe II ou modulator, sugerindo um car?ter modulat?rio da informa??o f?tica; A ZI do moc?, assim como em outros roedores e primatas, ? caracterizada por uma complexa rede neuroqu?mica, sobretudo na por??o medial da ZIr, onde encontramos imunorreatividade de todas as subst?ncias neuroativas investigadas, al?m de que A IR-NOS, GFAP e CR auxiliaram a delimita??o da ZI no n?vel m?dio em ZId e ZIv. Contudo, somente fibras IR 5-HT est?o presentes em todas as subdivis?es da ZI. Esses dados demonstram a grande riqueza neuroqu?mica da ZI do moc?, auxiliando para explicar o envolvimento em um amplo repertorio funcional